FDA
-
-
-
-
-
-
-
Angion Provides Corporate Update and Reports Second Quarter 2021 Financial Results
-
-
-
-
-
-
-
Angion and Vifor Pharma Announce Completion of Enrollment in Phase 2 Study of ANG-3777 for Cardiac-Surgery Associated Acute Kidney Injury
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

